Trial intelligence / Profile preview

Activated vs Non-activated PRP vs Hydrodissection in Carpal Tunnel Syndrome

NCT06249503Phase 4Completed

Sponsor
Ain Shams University
Start
Feb 2023
Primary completion
Sep 2024
Modality
Adoptive Cell Transfer
Countries
1
01

Overview

A Phase 4 trial of autologous platelet-rich plasma in carpal tunnel syndrome (CTS), sponsored by Ain Shams University. Started Feb 2023; status: completed.

02

Drugs

autologous platelet-rich plasma
03

Conditions

carpal tunnel syndrome (CTS)

Beyond the preview

Go deeper on NCT06249503.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06249503.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call